[Therapeutical trial in recovery room (author's transl)].

During a limited period of time, the authors have systematically administered tiapride to all patients in the immediate post-operative phase presenting with: nausea, vomiting, pain. Intravenous injection of a single dose of 400 mg of tiapride produces: a strong anti-emetic action; an inconstant analgesic action, but very interesting for it is not accompanied with adverse effects.